We have collected information about Atrigel Drug Delivery Technology for you. Follow the links to find out details on Atrigel Drug Delivery Technology.
http://www.imedpub.com/articles/atrigel-a-potential-parenteral-controlled-drug-delivery-system.pdf
The Atrigel Drug Delivery System The Atrigel system is a proprietary delivery system that can be used for both parenteral and site-specific drug delivery. Atrigel system was initially developed by Dunn and co-workers at Southern Research Institute in Birmingham, Alabama in 1987. The technology was licensed toAuthor: Karan Malik, Inderbir Singh, Manju Nagpal, eep Arora
http://ijbonline.com/article/208-213(ijbonline).pdf
The Atrigel® system is a proprietary delivery system that can be used for both parenteral and site-specific drug delivery. It consists of biodegradable polymers dissolved in a biocompatible carrier.
https://www.researchgate.net/publication/281688619_A_review_on_atrigel_drug_delivery_system
Atrigel® system is a proven sustained-release drug delivery platform that delivers therapeutic levels of a wide spectrum of drugs over a few days to several months with a single injection.Author: D.B. Patel
https://www.hilarispublisher.com/proceedings/atrigel-drug-delivery-system--an-approach-for-sustained-effect-893.html
The rationale for developing the ATRIGEL? technology was the need for a delivery system that had the simplicity and reliability of solid implant devices, but the convenience and ease of administration of microparticles.The Atrigel? system is a proven sustained-release drug delivery platform that delivers therapeutic levelsof a wide spectrum of ...
https://www.manufacturingchemist.com/news/article_page/Reckitt_Benckiser_licenses_Atrigel_Technology_from_QTL/41213
Sep 01, 2008 · Reckitt Benckiser licenses Atrigel Technology from QTL. 1-Sep-2008 . Reckitt Benckiser Pharmaceuticals Inc, based in Richmond, VA, has set up a licensing agreement with QLT USA, for Atrigel sustained-release drug delivery technology.
https://www.tandfonline.com/doi/abs/10.1517/13543784.7.9.1483
Jul 09, 2014 · (1998). The drug delivery and biomaterial attributes of the ATRIGEL®technology in the treatment of periodontal disease. Expert Opinion on Investigational Drugs: Vol. 7, No. 9, pp. 1483-1491.Author: GL Southard, RL Dunn, S Garrett
https://www.fiercebiotech.com/biotech/qlt-inc-qlti-announces-agreement-to-exclusively-license-atrigel-r-technology-to-reckitt
Aug 26, 2008 · QLT Inc. (QLTI) Announces Agreement to Exclusively License the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc.
https://www.researchgate.net/publication/266273152_Atrigel_A_potential_parenteral_controlled_drug_delivery_system
Atrigel: A potential parenteral controlled drug delivery system Article (PDF Available) in Der Pharmacia Sinica 1(1) · January 2010 with 1,533 Reads How we measure 'reads'
http://www.oalib.com/paper/2812366
Atrigel system is a proven sustained-release drug delivery platform that delivers therapeutic levels of a wide spectrum of drugs over a few days to several months with a single injection. Atrigel system is use for both parenteral and site-specific drug d...
https://pdfs.semanticscholar.org/d9ec/25acebcd1db49cb471210fea3f1644cb30f9.pdf
ATRIGEL® DRUG DELIVERY TECHNOLOGY The Atrigel® system is a proprietary delivery system that can be used for both parenteral and site-specific drug delivery. It consists of biodegradable polymers dissolved in a biocompatible carrier. When the liquid polymer system is placed in …
Searching for Atrigel Drug Delivery Technology?
You can just click the links above. The data is collected for you.
